Science & tech

The Medical Minute: Israeli Study Finds Anti-Cancer Potential in Cannabis

Published on April 23, 2015 · Last updated July 28, 2020

Scientists at the Technion-Israel Institute of Technology in Haifa recently released the preliminary results of a cancer study that examined the effects of 50 varieties of cannabis with 200 different cancer cells. While it’s still far too soon to draw any conclusions, their findings are cause for optimistic curiosity.

The researchers noticed that cannabinoids have the ability to slow tumor growth and even selectively promote cancer cell death in a process known as “apoptosis.” These findings replicate those uncovered in a Spanish study from 2013, which specifically looked at THC as a potential anti-cancer agent. Now scientists in Israel wonder how different combinations of cannabis derivatives, and their dose and delivery method, affect different types of cancer cells.

“There is a large body of scientific data which indicates that cannabinoids specifically inhibit cancer cell growth and promote cancer cell death,” said Dr. David Meiri, who leads the Israeli research team. “In addition to active cannabinoids, cannabis plants also contain a multitude of other therapeutic agents, such as terpenoids and flavonoids that are usually present in small quantities, but can have beneficial therapeutic effects, especially as synergistic compounds to cannabinoids.”

Meiri’s specialized area of study is cell cytoskeletons, which are directly involved in the movement and division processes of cancerous cells. In search of compounds that influence cell structure, Meiri arrived at cannabis and was eager to fill the void of knowledge surrounding it.

Cancer patients have been prescribed and using medical marijuana for pain, nausea, and appetite loss associated with treatment, but the growing body of evidence science has to offer makes one wonder what else cannabis is capable of.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Bailey Rahn
Bailey Rahn
Bailey is a senior content manager at Leafly, specializing in strains and health. She's spent 7+ years researching cannabis products, spreading patients’ stories, and exploring healthy ways of integrating cannabis into daily life.
View Bailey Rahn's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.